r&d

Research and Development Aurobindo's R&D strengths are in developing intellectual... Read More

api

Active Pharmaceutical Ingredients Aurobindo is one of the top API manufacturing companies... Read More

formulations

Formulations One of the largest vertically integrated companies in... Read More

crams

Crams AuroSource is the Custom Research and Manufacturing... Read More

  • Aurobindo’s European Subsidiary signs Binding Offer to acquire commercial operations in seven Western European Countries from Actavis
  • Aurobindo Pharma Ltd. launched its operations in the Kingdom of Bahrain through a grand event held at Hotel Radisson Blu on Monday, 17th Sep’2012. The event was inaugurated by Mr. Rajender Kumar, Attache of Indian Embassy of Bahrain and Dr. Sahar, Director of DMM, MOH, Bahrain. The event was well attended by the Medical fraternity of over 150 Doctors from the Private and Government segment, Ministry of Health, Bahrain
  • Aurobindo Pharma Ltd. launched its operations in Sultanate of Oman through a grand event held at Crowne Plaza on Monday, 4th June 2012. The event was inaugurated by the H.E. J S Mukul, the Indian Ambassador to Sultanate of Oman and was well attended by the Medical fraternity of Sultanate of Oman.
  • Aurobindo Pharma Ltd. launched its operations in Sultanate of Oman through a grand event held at Crowne Plaza on Monday, 4th June 2012. The event was inaugurated by the H.E. J S Mukul, the Indian Ambassador to Sultanate of Oman and was well attended by the Medical fraternity of Sultanate of Oman.
  • Removal of import alert by USFDA for Unit-VI of the Company: USFDA as per their website update, has lifted an import alert for non-sterile products manufactured in Aurobindo Pharma's UNIT-VI cephalosporin facility based in Hyderabad, India. This allows Aurobindo Pharma to resume the export of 9 products to the US market. Prior to the import alert, that was imposed in February 2011, the Unit made an annual US sales of USD 33 million for the said products.
   

Global leadership position In Anti-infectives

Among the largest ' Vertically Integrated ' pharmaceutical companies in India, Aurobindo has robust product portfolio spread over major product areas encompassing CVS, CNS, Anti-Retroviral, Antibiotics, Gastroenterologicals, Anti-Diabetics and Anti-Allergic with approved manufacturing facilities by USFDA, UKMHRA, WHO, MCC-SA, ANVISA-Brazil for both APIs & Formulations and...

More

Chairman's Message

Chairman

The pharmaceutical industry needs a high level of consistency in terms of quality of drugs and medicines.....

More